These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 2618015

  • 1. [Immune hemolytic anemia caused by catergen].
    Shinkov D, Urumov I, Doĭchinova N, Manolova V, Ananieva R.
    Vutr Boles; 1989; 28(5):84-7. PubMed ID: 2618015
    [Abstract] [Full Text] [Related]

  • 2. [Hemolytic anemia secondary to taking cyanidanol: demonstration of the mechanism of the erythrocyte damage].
    Beris P, Beyner F, Bisetti A, Zubler R, Miescher PA.
    Schweiz Med Wochenschr; 1986 Dec 13; 116(50):1763-6. PubMed ID: 3798066
    [Abstract] [Full Text] [Related]

  • 3. [Several years observation of a Catergen (cyanidanol-3) induced immunohemolysis].
    Stühlinger W, Berek K, Grösswang F, Schauer N.
    Schweiz Med Wochenschr; 1990 Mar 10; 120(10):345-8. PubMed ID: 2315653
    [Abstract] [Full Text] [Related]

  • 4. Immune-mediated acute intravascular hemolysis caused by cianidanol (catergen).
    Rotoli B, Giglio F, Bile M, Formisano S.
    Haematologica; 1985 Mar 10; 70(6):495-9. PubMed ID: 3938427
    [No Abstract] [Full Text] [Related]

  • 5. [Immunohematologic studies on the correlations between (+)-cyanidanol-3-(catergen) therapy and hemolytic anemia].
    Pausch V, Göbel J.
    Wien Med Wochenschr; 1983 Nov 15; 133(21):559-65. PubMed ID: 6419470
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment of chronic hepatitis patients with catergen].
    Karkishchenko NN, Okorokov AN, Fedorov NE, Laktionova AA, Sidorenko LF.
    Ter Arkh; 1986 Nov 15; 58(2):76-9. PubMed ID: 3704946
    [Abstract] [Full Text] [Related]

  • 9. [Catergen-induced immune hemolytic anemia following sensitization by other flavonoids].
    Quadri F, Neftel K, Zwahlen H, Marone C.
    Schweiz Rundsch Med Prax; 1987 Nov 24; 76(48):1338-40. PubMed ID: 3432825
    [No Abstract] [Full Text] [Related]

  • 10. Immune hemolytic anemia associated with sulindac.
    Johnson FP, Hamilton HE, Liesch MR.
    Arch Intern Med; 1985 Aug 24; 145(8):1515-6. PubMed ID: 4026480
    [Abstract] [Full Text] [Related]

  • 11. Effect of (+)-cyanidanol-3 (Catergen) in chronic active hepatitis. (Catergen plus prednisolone versus prednisolone in a controlled study).
    Pár A, Paál M, Kádas I, Kerekes E, Jávor T.
    Acta Med Hung; 1983 Aug 24; 40(1):17-24. PubMed ID: 6664741
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of chronic diseases of the liver with catergen].
    Loginov AS, Dzhalalov KD, Blok IuE, Bendikov EA, Ausheva LKh.
    Ter Arkh; 1986 Aug 24; 58(2):73-6. PubMed ID: 3704945
    [Abstract] [Full Text] [Related]

  • 13. Hemolytic anemia and thrombocytopenia induced by cyanidanol.
    Gandolfo GM, Girelli G, Conti L, Perrone MP, Arista MC, Damico C.
    Acta Haematol; 1992 Aug 24; 88(2-3):96-9. PubMed ID: 1466206
    [Abstract] [Full Text] [Related]

  • 14. Clinical, enzymological and histological changes in chronic diffuse liver diseases following (+)-cyanidanol-3 (Catergen) treatment.
    Halmy L, Dávid K, Nagy I, Stotz G, Kelemen JT.
    Acta Physiol Hung; 1984 Aug 24; 64(3-4):461-70. PubMed ID: 6152370
    [Abstract] [Full Text] [Related]

  • 15. Experiences with Catergen treatment in chronic active hepatitis.
    Pár A, Paál M, Kádas I, Nagy I, Kerekes E, Jávor T.
    Ther Hung; 1983 Aug 24; 31(3):105-14. PubMed ID: 6400472
    [No Abstract] [Full Text] [Related]

  • 16. [Detection of drug-induced antibodies to erythrocytes in the gel test].
    Kroll H, Salama A, Berghöfer H, Ernst-Schlegel M, Mueller-Eckhardt C.
    Beitr Infusionsther; 1993 Aug 24; 31():162-7. PubMed ID: 7693248
    [Abstract] [Full Text] [Related]

  • 17. Clinical and laboratory study of an episode of cefotetan-induced severe hemolytic anemia.
    Franchini M, Piccoli PL, Gandini G, Giuffrida A, Bressan F, De Gironcoli M, Aprili G.
    Hematology; 2004 Feb 24; 9(1):65-9. PubMed ID: 14965871
    [Abstract] [Full Text] [Related]

  • 18. [Chronic hemolytic anemia due to alphamethyldopa. Immunologic mechanism].
    Perreau P, Gardais J, Anjuere J, Guimbretière J.
    Presse Med (1893); 1969 Nov 22; 77(49):1821-2. PubMed ID: 4189111
    [No Abstract] [Full Text] [Related]

  • 19. Cefotetan-induced hemolytic anemia after perioperative prophylaxis.
    Martin ME, Laber DA.
    Am J Hematol; 2006 Mar 22; 81(3):186-8. PubMed ID: 16493619
    [Abstract] [Full Text] [Related]

  • 20. Hemolytic anemia.
    Dhaliwal G, Cornett PA, Tierney LM.
    Am Fam Physician; 2004 Jun 01; 69(11):2599-606. PubMed ID: 15202694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.